Public Policy vs TSS
PPHC and TSSI side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PPHC and TSSI compare
Public Policy is the larger company, worth 1.8 times as much as TSS ($291M against $159M).
Public Policy grew revenue faster over the last twelve months (24.7% versus −26.5% for TSS).
TSS keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with −20.9% at Public Policy.
Public Policy pays a dividend yielding 3.7%; TSS does not pay one.
TSS scores higher on the StockData Score (17 against 6 for Public Policy), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PPHC | TSSI |
|---|---|---|
| Size and price | ||
| Market cap | $291M | $159M |
| Share price | $9.64 | $5.63 |
| Change, 1 year | – | −34.8% |
| Change, 5 years | – | 950% |
| Beta (5Y) | – | 2.62 |
| Employees | 450 | 286 |
| StockData Score | ||
| Total score | 6 | 17 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 3 | 3 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | – | 11.7× |
| P/S | 1.6× | 0.8× (better) |
| P/B | 2.6× | 2.0× (better) |
| EV/EBITDA | – | 20.9× |
| P/FCF | 11.8× | – |
| FCF yield | 8.5% (better) | −13.2% |
| Fair value | $6.68 | $10.34 |
| Margin of safety | −44.4% | 45.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 24.7% (better) | −26.5% |
| Revenue growth, 5Y average | – | 40.4% |
| Net income growth (TTM) | – | 59.3% |
| EPS growth (TTM) | – | 37.1% |
| Profitability | ||
| Gross margin | 10.0% | 17.0% (better) |
| Operating margin | −18.2% | 2.0% (better) |
| Net margin | −20.9% | 7.4% (better) |
| FCF margin | 13.3% (better) | −10.9% |
| Return on equity | −40.6% | 32.0% (better) |
| Return on invested capital | −24.9% | 48.3% (better) |
| Financial health | ||
| Debt / equity | 0.38 | 0.20 (better) |
| Net debt / EBITDA | – | −10.05 |
| Interest coverage | −10.0× | – |
| Current ratio | 1.60 | 1.66 (better) |
| Altman Z-score | 0.73 | 2.13 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.7% | – |
| Buyback yield | – | 2.0% |
| Shareholder yield | 3.7% (better) | 2.0% |
| Ownership | ||
| Held by institutions | 22.7% | 46.3% |
| Held by insiders | 15.4% | 16.8% |
| Insider net buying, 12 months | −$2.1M (better) | −$8.9M |
| Short interest, % of float | 1.7% | 18.1% |
Go deeper
- PPHC stock overview
- PPHC income statement
- PPHC valuation and score
- TSSI stock overview
- TSSI income statement
- TSSI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.